More News

05 Dec 2018 Proposed Combination of Mereo BioPharma and OncoMed Pharmaceuticals
04 Dec 2018 Neurelis Announces Acquisition Of Aegis Therapeutics, A Leading Drug Delivery Technology Company
04 Dec 2018 Domain Therapeutics signs a multi-target research collaboration and license agreement with Boehringer Ingelheim
04 Dec 2018 Alteogen and Lynkogen Expand Agreement to Include Additional Proprietary Fusion Proteins Targeting NASH
04 Dec 2018 TRIGR Therapeutics Expands Bispecific Immuno-Oncology Pipeline with Exclusive Global License of Clinical Stage, Dual Angiogenesis Inhibitor from ABL Bio
03 Dec 2018 GSK reaches agreement to acquire TESARO, an oncology focused biopharmaceutical company
03 Dec 2018 Advanced Accelerator Applications signs exclusive option and license agreement with FUJIFILM Toyama Chemical to develop and commercialize radiolabeled FF-10158 for oncology indications
30 Nov 2018 MacroGenics and Zai Lab Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Margetuximab, MGD013 and TRIDENT™ Molecule in Greater China
29 Nov 2018 TRACON Pharmaceuticals and I-Mab Biopharma Announce Strategic Partnerships for Multiple Immuno-Oncology Programs
28 Nov 2018 HOOKIPA and DarwinHealth Enter into a Research Collaboration and License Agreement to Discover and Prioritize Novel Immunogenic, Tumor-Specific Cryptic Antigens
28 Nov 2018 Arsanis and X4 Pharmaceuticals Agree to Merger
28 Nov 2018 Zymeworks and BeiGene Announce License and Collaboration Agreement for Zymeworks’ HER2-Targeted Therapeutic Candidates, ZW25 and ZW49, in Asia-Pacific and Research and License Agreement for Zymeworks’ Azymetric™ and EFECT™ Platforms Globally
28 Nov 2018 Genentech Acquires Jecure Therapeutics
28 Nov 2018 Daiichi Sankyo and Roche to Collaborate on New HER2 Low Companion Diagnostic Test
27 Nov 2018 Tactiva Therapeutics Announces License to Oncolytic Vaccinia Virus Armed With CXCR4 Antagonist for Treatment of Ovarian Cancer
27 Nov 2018 Edge Therapeutics Enters into Merger Agreement with PDS Biotechnology to Form Clinical-Stage Cancer Immunotherapy Company
26 Nov 2018 REGENXBIO and Rocket Pharmaceuticals Announce New License Agreement for the Treatment of Danon Disease Using NAV AAV9 Vector
23 Nov 2018 Astellas Executes License Agreement with an Option to Acquire JVS-100 Gene Therapy Program from Juventas
21 Nov 2018 LEO Pharma and PellePharm Announce $760 Million Collaboration to Advance Innovative Therapies for Rare Skin Diseases
20 Nov 2018 Roivant Sciences and iNtRON Bio Sign Licensing Deal for Novel Anti-Superbugs Biologic SAL200
20 Nov 2018 GeoVax and Leidos Enter into a Collaboration Agreement on Immunotherapy Research Program
20 Nov 2018 GEn1E Lifesciences Adds to Development Pipeline with Exclusive Option to License University of Maryland, Baltimore’s MUC1-Ecto-Domain Anti-Bacterial Agent
20 Nov 2018 Bioblast Pharma Ltd. Announces Entry Into Merger Agreement to Acquire Enlivex Therapeutics Ltd. to Advance Clinical Stage Immunotherapeutic Drug Pipeline for the Treatment of Life-Threatening Diseases Sepsis, GvHD and Solid Tumors
19 Nov 2018 Alvotech and Fuji Pharma Enter into Exclusive Partnership for Development and Commercialization of Biosimilars in Japan
16 Nov 2018 MorphoSys and I-Mab Sign Strategic Partnering Agreement for MorphoSys's Novel Immuno-Oncology Agent MOR210

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up